Continuum Economics Revenue and Competitors
Estimated Revenue & Valuation
- Continuum Economics's estimated annual revenue is currently $2.8M per year.
- Continuum Economics's estimated revenue per employee is $141,400
Employee Data
- Continuum Economics has 20 Employees.
Continuum Economics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP SALES | Reveal Email/Phone |
2 | Marketing Director | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | IT Manager | Reveal Email/Phone |
5 | Economic Assistant | Reveal Email/Phone |
6 | Account Manager EMEA | Reveal Email/Phone |
7 | Senior Technical Strategist | Reveal Email/Phone |
8 | Senior Economist Latin America | Reveal Email/Phone |
9 | Senior Economist Western Europe UK, Eurozone | Reveal Email/Phone |
10 | Economist Asia/Pacific | Reveal Email/Phone |
Continuum Economics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.8M | 20 | N/A | N/A | N/A |
What Is Continuum Economics?
Continuum Economics is a leading independent macroeconomic, policy and financial markets research firm. Our worldwide client base consists of over 600 banks, asset managers, corporations, central banks and government organisations. Research is produced from our London, New York and Singapore research centres for a global audience. Clients and the marketplace tell us they value a number of elements of our research, including
keywords:N/A
N/A
Total Funding
20
Number of Employees
$2.8M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Continuum Economics News
2022-04-17 - What's driving the transition to value-based care? Medical Economics
What's driving the transition to value-based care? Medical Economics
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.1M | 20 | -46% | $25.1M |
#2 | $2M | 20 | 0% | N/A |
#3 | $3.5M | 20 | -31% | N/A |
#4 | $2M | 20 | 5% | N/A |
#5 | $2M | 20 | -13% | N/A |